recombinant human thrombopoietin (Jiangsu Kanghe Biotechnology)

N/A

Report date: 2025/03/20 10:06:14

Base Information

Drug Namerecombinant human thrombopoietin (Jiangsu Kanghe Biotechnology)
Drug Alias Namerh-TPO (Jiangsu Kanghe Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionThrombopoietin receptor agonists
TargetsThrombopoietin receptor
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAIM Action Biopharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAIM Action Biopharm Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombocytopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A